Bioequivalance: Clinical Trials

9 completed. 5 Not applicable, 4 Phase 1.

By phase and status

Phase	Trials	Status
Not applicable	5	Completed 5
Phase 1	4	Completed 4

Follow Bioequivalance: new trials by email Literature Review of Bioequivalance trials Research Report on Bioequivalance

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Clinical Study to Determine Bioequivalence of Oral Tamsulosin Products as 0.4 mg Prolonged-release Tablets in Male Subjects Under Fasted Conditions TAMSULOSIN TEST, OMNIC OCAS REFERENCE - Bioequivalance	Not applicable	Completed	ADIUM	34	2026-01-12	2026-07-13
Clinical Study to Determine Bioequivalence Between Two Oral Medications of Sitagliptin/Metformin in Prolonged-release Tablets With 100 mg/1000 mg in Healthy Subjects, Fed Study. Janumet XR, Sitagliptin/Metformin FDC - Bioequivalance	Not applicable	Completed	ADIUM	46	2025-12-08	2026-08-14
Clinical Study to Determine Bioequivalence Between Two Oral Medications of Sitagliptin/Metformin in Prolonged-release Tablets With 100 mg/1000 mg in Healthy Subjects, Fast Study. Janumet XR, Sitagliptin/Metformin FDC - Bioequivalance	Not applicable	Completed	ADIUM	46	2025-12-03	2026-08-14
Clinical Study to Determine Bioequivalence Between Two Oral Medications of Sitagliptin/Metformin in Prolonged-release Tablets With 50 mg/1000 mg in Healthy Subjects, Fast Study. Sitagliptin/Metformin FDC, Janumet XR - Bioequivalance	Not applicable	Completed	ADIUM	46	2025-11-19	2026-08-14
An Open-label, Randomized, Single-dose, Two-treatment, Four-period, Fully Replicate Crossover Bioequivalence Study in Healthy Female Adult Participants Under Fasting Conditions Comparing the Test Product, Prontogest Solution for IM Injection With the Reference Product, Progesterone Injection Progesterone IM of 100 mg - Bioequivalance, Post-menopause	Phase 1	Completed	Zi Diligence Biocenter	26	2025-11-10	2026-03-27
Bioequivalence Study of Vortioxetine in 20 mg Coated Tablets in Healthy Subjects Under Fasting Conditions Reference, Test - Bioequivalance	Phase 1	Completed	ADIUM	20	2025-03-18	2026-06-03
Bioequivalence Study of EMPAGLIFLOZIN (25 mg Tablets) vs. JARDIANCE® (25 mg Tablets), in Healthy Research Subjects, Under Fasting Conditions Empagliflozin (Jardiance®), Empagliflozin (oral) - Bioequivalance	Not applicable	Completed	ADIUM	32	2024-11-29	2026-03-18
Bioavailability of Trazodone Hydrochloride (New Polymer) vs. Trazodone Hydrochloride Contramid® at Steady-state. 150 mg trazodone hydrochloride, 300 mg trazodone hydrochloride - Bioavailability Heathy Volunteers, Bioavailability Study	Phase 1	Completed	Aziende Chimiche Riunite Angelini Francesco S.p.A	64	2024-05-22	2025-09-03
Bioequivalence Study Assessing Iron Sucrose or Venofer® in Healthy Adult Subjects Iron Sucrose Injection, Venofer Injection - Bioequivalance	Phase 1	Completed	Baxter Healthcare Corporation	196	2019-09-19	2020-07-31

Interventions

Sitagliptin Phosphate (3)  ·  Sitagliptin Phosphate, Metformin Hydrochloride Drug Combination (3)  ·  Metformin (2)  ·  Ferric Oxide, Saccharated (1)  ·  Progesterone (1)  ·  Trazodone (1)  ·  empagliflozin (1)

Sponsors

ADIUM (6)  ·  Aziende Chimiche Riunite Angelini Francesco S.p.A (1)  ·  Baxter Healthcare Corporation (1)  ·  Zi Diligence Biocenter (1)

Countries

Mexico (6)  ·  Egypt (1)  ·  Germany (1)  ·  United States (1)

Top investigators

Amira Gouda, PhD Analytical Chemistry (1)  ·  Eman Nouman, PhD, Analytical Chemistry (1)  ·  Mohammed Abdulhafez, MBBCH (1)  ·  Mostafa Salah, MSc, Pharmacology & Toxicology (1)

Results publications

PMID 42228061, PMID 42515774, PMID 42654125